NOVO.B.DK

235.9

-1.13%↓

GMAB.DK

1,680

+1.54%↑

HLUNB.DK

37.74

-0.11%↓

ZEAL.DK

289.3

+3.99%↑

AMBUB.DK

68.2

+0.37%↑

NOVO.B.DK

235.9

-1.13%↓

GMAB.DK

1,680

+1.54%↑

HLUNB.DK

37.74

-0.11%↓

ZEAL.DK

289.3

+3.99%↑

AMBUB.DK

68.2

+0.37%↑

NOVO.B.DK

235.9

-1.13%↓

GMAB.DK

1,680

+1.54%↑

HLUNB.DK

37.74

-0.11%↓

ZEAL.DK

289.3

+3.99%↑

AMBUB.DK

68.2

+0.37%↑

NOVO.B.DK

235.9

-1.13%↓

GMAB.DK

1,680

+1.54%↑

HLUNB.DK

37.74

-0.11%↓

ZEAL.DK

289.3

+3.99%↑

AMBUB.DK

68.2

+0.37%↑

NOVO.B.DK

235.9

-1.13%↓

GMAB.DK

1,680

+1.54%↑

HLUNB.DK

37.74

-0.11%↓

ZEAL.DK

289.3

+3.99%↑

AMBUB.DK

68.2

+0.37%↑

Search

Coloplast A-S (Class B)

Fechado

431.7 0.42

Visão Geral

Variação de preço das ações

24h

Atual

Mín

429

Máximo

435.1

Indicadores-chave

By Trading Economics

Rendimento

522M

1.4B

Vendas

83M

7B

P/E

Médio do Setor

24.382

57.05

EPS

6.32

Rendimento de Dividendos

5.47

Margem de lucro

19.835

Funcionários

16,983

EBITDA

309M

2.3B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.86% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.47%

2.52%

Próximos Ganhos

12 de mai. de 2026

Próxima data de dividendos

20 de mai. de 2026

Próxima data de ex-dividendo

18 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-21B

97B

Abertura anterior

431.28

Fecho anterior

431.7

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

25 de mar. de 2026, 20:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Infosys Agrees to Acquire Stratus

25 de mar. de 2026, 23:58 UTC

Ganhos

Guming Proposes 2025 Final Dividend of HK$0.50 >1364.HK

25 de mar. de 2026, 23:58 UTC

Ganhos

Guming: Seek to Further Expand Coffee Product Line, Explore New Food Categories >1364.HK

25 de mar. de 2026, 23:57 UTC

Ganhos

Guming: Aim to Expand Store Network in China, Evaluate Overseas Opportunities >1364.HK

25 de mar. de 2026, 23:57 UTC

Ganhos

Guming Store Network Rose 37% on Year to 13,554 Stores as of Dec. 31, 2025 >1364.HK

25 de mar. de 2026, 23:56 UTC

Ganhos

Guming 2025 Rev CNY12.91B Vs. CNY8.79B >1364.HK

25 de mar. de 2026, 23:56 UTC

Ganhos

Guming 2025 Net CNY3.11B Vs. Net CNY1.48B >1364.HK

25 de mar. de 2026, 23:41 UTC

Conversa de Mercado

Nikkei May Trade Rangebound Amid Uncertainty Over U.S.-Iran Talks -- Market Talk

25 de mar. de 2026, 23:41 UTC

Ganhos

These Stocks Are Today's Movers: Arm, Intel, AMD, Firefly Aerospace, Robinhood, JD.com, Sarepta, and More -- Barrons.com

25 de mar. de 2026, 23:34 UTC

Conversa de Mercado
Notícias Principais

Gold Declines on Possible Technical Correction -- Market Talk

25 de mar. de 2026, 22:08 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

25 de mar. de 2026, 22:08 UTC

Conversa de Mercado

Synlait Milk's Outlook Depends on Dunsandel -- Market Talk

25 de mar. de 2026, 22:07 UTC

Ganhos

China Mengniu Dairy: Weak Consumer Demand Weighed on Rev >2319.HK

25 de mar. de 2026, 22:07 UTC

Ganhos

China Mengniu Dairy Plans Steady Increase in Dividends For Next Three Years >2319.HK

25 de mar. de 2026, 22:07 UTC

Ganhos

China Mengniu Dairy: 2025 Net Supported by Absence of Impairment Provisions Made Last Year >2319.HK

25 de mar. de 2026, 22:07 UTC

Ganhos

China Mengniu Dairy 2025 Rev CNY82.24B Vs. CNY88.67B >2319.HK

25 de mar. de 2026, 22:07 UTC

Ganhos

China Mengniu Dairy 2025 Net CNY1.55B Vs. Net CNY104.51M >2319.HK

25 de mar. de 2026, 21:58 UTC

Conversa de Mercado

Amplitude Energy Oversold on Isabella-1 Well Disappointment -- Market Talk

25 de mar. de 2026, 21:37 UTC

Conversa de Mercado

Miran: AI and Deregulation Are Positive Supply Shocks To Economy -- Market Talk

25 de mar. de 2026, 21:14 UTC

Aquisições, Fusões, Aquisições de Empresas

St Barbara: Expects to Record Gain on Sale of Roughly A$500 Million Upon Completion

25 de mar. de 2026, 21:13 UTC

Aquisições, Fusões, Aquisições de Empresas

St Barbara: All Conditions Satisfied, Waived on Lingbao Deal

25 de mar. de 2026, 21:12 UTC

Aquisições, Fusões, Aquisições de Empresas

Closing M&A Deals Bring Opportunity. Janus Henderson and Other Stocks to Buy. -- Barrons.com

25 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

25 de mar. de 2026, 20:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

25 de mar. de 2026, 20:33 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR & Co.: Entered Agreement to Sell CoolIT Systems to Ecolab in Transaction Valued at $4.75B >KKR >KKR

25 de mar. de 2026, 20:31 UTC

Ganhos

The SpaceX IPO Is Coming. Cathie Wood's Ark Venture and More Funds to Get in on the Action. -- Barrons.com

25 de mar. de 2026, 20:15 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR Scores One of Its Best Bets With Sale of Data-Center Cooling Business -- WSJ

25 de mar. de 2026, 20:15 UTC

Aquisições, Fusões, Aquisições de Empresas

CoolIT Employees Set to Receive Average Payouts of $240,000, Executives Say -- WSJ

25 de mar. de 2026, 20:15 UTC

Aquisições, Fusões, Aquisições de Empresas

CoolIT Deal Ranks Among KKR's Top-4 Highest Earning Investments in Past 20 Years, Executives Say -- WSJ

25 de mar. de 2026, 20:15 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR Set to Make 15x Investment From $4.75B Sale of CoolIT to Ecolab, Executives Say -- WSJ

Comparação entre Pares

Variação de preço

Coloplast A-S (Class B) Previsão

Preço-alvo

By TipRanks

11.86% parte superior

Previsão para 12 meses

Média 901.38 DKK  11.86%

Máximo 1,056 DKK

Mínimo 720 DKK

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

2

Comprar

4

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat